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Because of poor survival of probiotic bacteria, microencapsulation 
evolved from the immobilized cell culture technology is used in the 
biotechnological industry. Bifidobacterium (BB-12) and Lactobacillus 
acidophilus (LA-5) were immobilized in calcium alginate by extrusion 
method. Encapsulation parameters and efficacy were evaluated. 
Growth factors of the above two bacteria were also measured by 
culturing in fermenter. Growth trend was obtained with respect to 
optical density and dry biomass weight. Encapsulation yield was over 
60% in each experiment. Scanning electron microscopy of entrapment 
of cells in alginate matrix and cross-sections of dried bead were 
obtained and illustrated. According to fermentation results, 
Bifidobacterium BB-12 shows better biotechnological properties. 
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According to FAO/WHO, probiotics are living 
microorganisms that, when administered in adequate 
amounts, confer a health benefit on the host [1]. 
Probiotic bacteria have been reported to suppress the 
growth of pathogens [2,3], prevention of diarrhea and 
constipation diseases [4-6], improvement of lactose 
utilization by producing β-galactosidase [6,7], and 
prevention of cancer and mutation activities in the 
human gut [8,9]. 
Due to the particular nature of many probiotic 
bacteria, survival during the processing and storage of 
functional foods and during passage through the 
human gastrointestinal tract remains major challenges 
for effective delivery of these beneficial bacteria [10]. 
Providing probiotic living cells with a physical barrier 
against adverse environmental conditions is among the 
approaches currently receiving considerable interest. 
The technology of microencapsulation of probiotics 
 
 
 has evolved from the immobilized cell culture 
technology used in the biotechnological industry. 
Immobilization in polymer provides a physical 
retention of cells. It facilitates the purification process 
and separation of cells from metabolites. Encapsulation 
is used to enhance viability, stability, and protection of 
lactic cultures [11]. The majority of materials used for 
formation of microcapsules are natural or synthetic 
polymers. Several characteristics and qualities should 
be taken into account for choosing polymers for this 
purpose [12]. Among the various carriers such as 
chitosan, carrageenan and gelatin, microencapsulation 
in calcium alginate network has been widely used for 
the immobilization of lactic acid bacteria due to its 
ease of handling, nontoxic nature, and low cost 
[13,14]. Alginates are natural unbranched binary 
copolymers of 1-4 linked s-D-mannuronic acid (M) 
and a-L-guluronic acid (G) [12].  
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On the other hand, many strains of intestinal 
origin are difficult to propagate. The most frequently 
used bacteria in probiotic products include the 
Lactobacillus (L.) and Bifidobacterium (B.) species 
[15]. Lactobacilli have complex growth requirements. 
Bifidobacteria are anaerobic micro-organisms [16]. 
Thus, producing these bacteria on large scale is in 
much demand in probiotic industry, and most 
commercial strains are selected on the basis of their 
technological properties. Industrial processes for food 
culture production, including probiotics, almost 
exclusively use conventional batch fermentation with 
suspended cells [17]. 
In this study, encapsulating of two commercial 
probiotic strains was performed, and the yields of 
the products were measured. Furthermore, to 
evaluate the growth in large scale based on substrate 
utilization and biomass production, fermentation of 
these strains was performed separately using 10-l 
fermenter. 
 
2. Materials and Methods  
2.1. Materials 
 
Sodium alginate was obtained from Sigma 
Aldrich (USA). Calcium chloride, L-cysteine-HCl, 
MRS medium (broth and agar), glucose, yeast extract 
and other materials were supplied by Merck 
Germany. B. animalis subsp. lactis strain BB-12 and 
L. acidophilus strain LA-5 were obtained from 
Christian Hansen (Denmark(. 
 
2.2. Microencapsulation of microorganisms 
 
To achieve biomass for encapsulation, freeze-
dried cells were suspended in sterile physiological 
serum, and after inoculating on MRS agar, incubated 
at 37°C for 2 days. The cells were sub-cultured twice 
in 50 ml and 150 ml MRS broth under the same 
conditions. After 20 h, the cells were harvested by 
centrifuging at 3800×g (4°C and 20 min), washed 
with sterile physiological serum, and then collected 
by centrifugation. L. acidophilus LA-5 was incubated 
under aerobic conditions while Bifidobacterium BB-
12 was cultured in a medium supplemented with 0.5 
gl-1 L-cysteine hydrochloride and incubated anaer-
obically using the Gas Pack system. 
The extrusion technique of microencapsulation 
was used [18]. For each strain, encapsulation was 
performed with freeze-dried bacteria (used intact as 
supplied by the manufacturer) and also with fresh 
biomass, which was obtained as described in the 
previous section . 
The alginate mixture was prepared by adding 
sodium alginate in distilled water and 5% freeze-
dried cells in physiological serum; then they were 
mixed together. The cell pellet was re-suspended in 
saline solution and mixed with sodium alginate 
solution. In both procedures, a cell suspension with 
the final concentration of 2% (ww-1) alginate was 
achieved . 
Microbial suspension was introduced in a stainless 
steel device designed particularly for this study 
(Dissertation of Jamshid Fooladi, Braunschweig, 
Germany 1990). This devise has three main parts; a 
column, a cap with an inlet for air pressure system 
and lower part with one inlet for air (use of this inlet 
is optional), and one outlet, which can fit on syringe 
needle. Its outlet was fitted on a 27.5 G needle. The 
suspension was dropped aseptically into 250 ml of 0.1 
M calcium chloride (using sterile air pressure), which 
caused the droplets to harden in sphere shapes with 
gentle agitation. After 30 min, the beads were 
separated by decantation and rinsed with 0.1 M 
calcium chloride [19]. The distance between the 
syringe and CaCl2 solution was 20 cm [20]. 
 
2.3. Calculation of encapsulation parameters 
 
For dissolution of alginate beads, citrate buffer 
(pH=6.8) was used since citrate chelate calcium ions 
weaken alginate network for effective release of 
cells [21]. The samples were diluted to appropriate 
concentrations, and pour plated in MRS agar. The 
plates were incubated for three days at 37˚C, and the 
encapsulated bacteria were enumerated as CFU ml-1 
(colony forming unit per milliliter). The encapsulation 
yield (EY), which is a combination measurement of the 
efficacy of entrapment and survival of viable cells 
during the microencapsulation procedure, was 
calculated as EY= N/N0×100; where, N is the number 
of viable entrapped cells released from the beads, and 
N0 is the number of free cells added to the 
biopolymer mix during the production of beads [22]. 
Cell load of the beads (number of the cells in each 
bead) was calculated by dividing the amount of cells 
to the number of beads in each sample.  
Survival of encapsulated L. acidophilus LA-5 in 
CaCl2 (0.1 M) and distilled water during two weeks at 
4°C was compared. 
 
2.4. Electron microscopy 
 
A sample of beads containing biomass of 
Bifidobacterium BB-12 was air dried at 4˚C. After 
gold coating, entrapment of cells in alginate matrix 
and cross-sections of the dried beads were analyzed 
by scanning electron microscopy (SEM) (TESCAN, 
VEGA), and the photos were taken at different 
magnifications . 
 
2.5. Cell growth of strains 
 
Fermentations were done without aeration in a 
10-l laboratory bioreactor (Bench Top Fermentation 
System – Major Science) with pH, temperature and 
agitation control. Consumption of sugar in anaerobic 
conditions resulted to produce acids and reduce pH; 
this was, consequently, compensated by adding NaOH 
automatically. Inoculation was done at 8% (L. 
acidophilus LA-5) and 6% (Bifidobacterium BB-12) 
using the same medium as fermentation for each 
strain. 
Yari et al. 
 
Appl Food Biotechnol, Vol. 2, No. 4 (2015)                                                                                                          29    
 
2.5.1. L. acidophilus LA-5 
 
Fermentation was carried out in MRS medium at 
a constant pH of 6±0.5. The pH was kept constant 
by the automatic addition of 10 N NaOH solution. 
The fermentation temperature was adjusted at 37˚C, 
and the agitation rate was fixed at 100 rpm [23]. 
 
2.5.2. Bifidobacterium BB-12 
 
The cultivation medium contained yeast extract 
30 gl-1, glucose 20 gl-1, phosphates (K2HPO4 and 
NaH2PO4) 4 gl
-1, Tween 80 1 gl-1, L-cysteine-HCl 1 
gl-1, and MgSO4 0.2 gl
-1 [24]. The pH was kept 
constant using 4 N NaOH .The fermentation 
temperature was kept at 37°C and the agitation rate 
was fixed at 60 rpm. 
During the fermentation, the hourly samples were 
withdrawn aseptically for analysis of cell growth and 
sugar consumption. Cell growth was measured by 
optical density at 650 nm (OD650), and cell dry mass 
(CDM, expressed in g ml-1) was measured after 72 h 
incubation at 105°C. In the samples having OD 
values above 0.9, dilutions were carried out before 
the final OD determination. Sugar level was 
determined by phenol sulfuric acid method [25, 26]. 
 
3. Statistical analysis 
 
The data were analyzed using the SPSS software 
(ver.14). All means±SEM (in triplicate) were 
compared with One-Way ANOVA. The differences 
were considered significant at p<0.05. 
 
4. Results and Discussion  
 
In this study, two challenges of probiotic industry, 
microencapsulation and fermentation, were evaluated 
for two probiotic strains. Numerous encapsulation 
strategies have been evaluated for their ability to 
protect probiotics from environmental stresses; most 
of them using alginate, which presents the benefits of 
being non-toxic, biodegradable and biocompatible. 
Encapsulation process resulted to the formation of 
spherical beads containing bacteria. The initial 
number of viable L. acidophilus LA-5 in aqueous 
suspension used to prepare the beads was 2.76±0.35× 
1010 CFU. After encapsulation, the number of viable 
cells recovered in pH 6.8 citrate buffer was 
1.06±0.47×109 CFU g-1 of beads. The encapsulation 
yield was calculated as 77±9%, and the cell load was 
5.45±0.35× 106 CFU. About Bifidobacterium BB-12, 
the number of viable cells in sodium alginate 
suspension was 1.38±0.04× 1011 CFU. The number of 
viable bacteria per gram of bead was 7.3±3.4×109 
CFU. The yield of encapsulation for this strain was 
calculated as 82±9%, and the cell load was 
3.81±1.81×107 CFU. Although encapsulation techno-
logy was developed to protect cells against harsh 
conditions, the process itself can cause missing some 
cells. Extrusion is the simplest and most common 
technique used to produce probiotic capsules with 
hydrocolloids [27]. The mild formulation conditions 
used to produce alginate beads by cross-linking 
alginate with Ca2+ divalent cations allowed the 
encapsulation of both probiotic bacteria with minimum 
effect on their viability and good entrapment 
efficiency. Encapsulation yield was over 60% in all 
experiments without any significant difference 
between the two species. Since, after ion exchange of 
sodium alginate with CaCl2 and formation of beads a 
portion of the initial water maintains in the calcium 
alginate network, N and N0 were calculated with 
respect to the weight of initial suspension and the 
weight of final beads. 
Like this study, Graff et al. used alginate for 
encapsulation of yeast cells by extrusion method, and 
the obtained yield was reported to be 87% [28]. 
Extrusion method is usually done by syringe in 
laboratory scale [20, 29]. To make a model for 
industrializing the process, stainless steel device with 
higher suspension capacity was used. 
The number of encapsulated L. acidophilus LA-5 
cells in CaCl2 and distilled water at 4˚C is shown in 
Figure 1. After 15 days, the number of survived 
encapsulated cells kept in CaCl2 was about 2.8 logs 
more than beads in distilled water. More survival of 
encapsulated cells kept in CaCl2 solution can be due 
to more stability of the alginate network in this 
condition. 
Alginate beads were spherical with wrinkled surface. 
The wrinkle surface was probably due to the drying 
process and loss of water content (Figure 2). 
 
4.1. Fermentation process 
 
In the fermentation process, Bifidobacterium BB-12 
grows better than L. acidophilus LA-5, and produces 
more biomass. L. acidophilus LA-5 reached a maximal 
biomass of about 1.2 g CDM l-1, while the amount of 
biomass for Bifidobacterium BB-12 strain was 3.9 g 




Figure 1. Survival curves of encapsulated L. acidophilus 




























Encapsulation and Fermentation of Probiotics 
 
30                                                                                                          Appl Food Biotechnol, Vol. 2, No. 4 (2015) 
 
 
Figure 2. Micrograph of the beads containing Bifidobacterium BB-12 encapsulated in alginate (Magnification: a: ×187, b: 
×500, c: ×1500, d: ×3500, e: ×7500, f: ×15000). 
 
 




Figure 3. Growth curves of L. acidophilus LA-5 (top) and Bifidobacterium BB-12 (down) base on optical density (●), cell mass 
(■) and glucose consumption (▲). 
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In the primary experiment, L. acidophilus LA-5 
did not grow well in the prepared media like 
Bifidobacterium BB-12. Thus, the procedure of 
Avonts et al. was performed in this study using 
MRS medium, preferably for 10 L fermentation of 
this strain. Most strains of bifidobacteria are unable 
to grow in a totally synthetic medium and require 
complex nitrogenous substrates. Thus, the Kiviharju 
et al. procedure was applied in the case of Bifido-
bacterium BB-12 propagation [24].  
Although Bifidobacterium BB-12 is an anaerobic 
strain, CO2 was not used. L-cysteine acts as oxygen 
scavenger, and maintains low redox potential. Bifid-
obacteria are considered anaerobic; however, the 
degree of tolerance to oxygen depends on the species 
and the culture medium [30]. In a study, growth of  
B. infantis in aerated fermentation was evaluated by 
Gonzalez et al. Their results indicated that these 
bacteria are able to grow in the presence of up to 80% 
DO (dissolved oxygen), showing a high aerotolerance 
under the conditions used in that work (starting 
fermentations in the absence of oxygen) [31]. 
Nowadays, most commercial strains are selected on 
the basis of their technological properties, and can be 
produced on a large scale. However, still there are a lot 
of differences among these strains. Thus choosing the 
best strain for each process or optimizing the process for 
each specific strain should be considered, and are much 




Two probiotic strains, Bifidobacterium BB-12 and 
L. acidophilus LA-5, were immobilized in calcium 
alginate by extrusion method. Stainless steel device 
with higher capacity for suspension was a model 
instrument for industrializing of the process. The mild 
formulation conditions used to produce alginate beads 
allowed the encapsulation of both probiotic bacteria with 
minimum effect on their viability and good entrapment 
efficiency. 
Although both strains are industrial probiotic strains, 
with conventional culturing media and method, Bifido-
bacterium BB-12 grew better and produced more 
biomass. This result indicates that L. acidophilus LA-5 
needs more optimization than Bifidobacterium BB-12 
for large-scale production. 
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